Tuyen T. Nguyen

Array ( [id] => 1341198 [patent_doc_number] => 06589973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Preparation of selective cyclooxygenase II inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/146674 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5317 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589973.pdf [firstpage_image] =>[orig_patent_app_number] => 10146674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6705796 [patent_doc_number] => 20030152530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Mouthwash compositions' [patent_app_type] => new [patent_app_number] => 10/146500 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152530.pdf [firstpage_image] =>[orig_patent_app_number] => 10146500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736068 [patent_doc_number] => 20030013703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization' [patent_app_type] => new [patent_app_number] => 10/144669 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21626 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013703.pdf [firstpage_image] =>[orig_patent_app_number] => 10144669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425553 [patent_doc_number] => 06503915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-07 [patent_title] => 'Composition and method for treatment of cerebral ischemia' [patent_app_type] => B2 [patent_app_number] => 10/140703 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 2048 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503915.pdf [firstpage_image] =>[orig_patent_app_number] => 10140703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333302 [patent_doc_number] => 06596715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/129671 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6148 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596715.pdf [firstpage_image] =>[orig_patent_app_number] => 10129671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347682 [patent_doc_number] => 06583137 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/129674 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6267 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583137.pdf [firstpage_image] =>[orig_patent_app_number] => 10129674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440536 [patent_doc_number] => 20020128322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Compositions including modafinil for treatment of eating disorders and for appetite stimulation' [patent_app_type] => new [patent_app_number] => 10/138224 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3838 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128322.pdf [firstpage_image] =>[orig_patent_app_number] => 10138224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778121 [patent_doc_number] => 20030049202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Method of using gadolinium neutron capture to treat cancers' [patent_app_type] => new [patent_app_number] => 10/135069 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12706 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049202.pdf [firstpage_image] =>[orig_patent_app_number] => 10135069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535804 [patent_doc_number] => 20020193286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog' [patent_app_type] => new [patent_app_number] => 10/136140 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9217 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193286.pdf [firstpage_image] =>[orig_patent_app_number] => 10136140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749840 [patent_doc_number] => 20030044360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Process and composition for high efficacy teeth whitening' [patent_app_type] => new [patent_app_number] => 10/125787 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3995 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044360.pdf [firstpage_image] =>[orig_patent_app_number] => 10125787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425847 [patent_doc_number] => 06503948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-07 [patent_title] => 'Method for prevention or treatment of acute allograft rejection and a pharmaceutical composition therefor' [patent_app_type] => B2 [patent_app_number] => 10/123185 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2213 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503948.pdf [firstpage_image] =>[orig_patent_app_number] => 10123185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800766 [patent_doc_number] => 20030095930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Composition for oral hygiene' [patent_app_type] => new [patent_app_number] => 10/122977 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5945 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095930.pdf [firstpage_image] =>[orig_patent_app_number] => 10122977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108088 [patent_doc_number] => 06809120 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Composition containing propargylamine for enhancing cancer therapy' [patent_app_type] => B1 [patent_app_number] => 09/600125 [patent_app_country] => US [patent_app_date] => 2002-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5098 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809120.pdf [firstpage_image] =>[orig_patent_app_number] => 09600125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381624 [patent_doc_number] => 20020119978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Composition and method for decreasing neurologic symptomatology' [patent_app_type] => new [patent_app_number] => 10/116840 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2779 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119978.pdf [firstpage_image] =>[orig_patent_app_number] => 10116840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716470 [patent_doc_number] => 20030027818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Treatment of cancers' [patent_app_type] => new [patent_app_number] => 10/109058 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6419 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027818.pdf [firstpage_image] =>[orig_patent_app_number] => 10109058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6330129 [patent_doc_number] => 20020198247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR INHIBITING THE GROWTH OF VIRUSES AND CANCERS' [patent_app_type] => new [patent_app_number] => 10/106429 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13940 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198247.pdf [firstpage_image] =>[orig_patent_app_number] => 10106429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220872 [patent_doc_number] => 06703400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Methods for treating multidrug resistance' [patent_app_type] => B2 [patent_app_number] => 10/104554 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15769 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703400.pdf [firstpage_image] =>[orig_patent_app_number] => 10104554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177934 [patent_doc_number] => 20020156068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Anti-psychosis combination' [patent_app_type] => new [patent_app_number] => 10/104602 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9149 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156068.pdf [firstpage_image] =>[orig_patent_app_number] => 10104602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337457 [patent_doc_number] => 06593316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Use of 5-androstene-3ol-7,17-dione in the treatment of lupus erythematosus' [patent_app_type] => B2 [patent_app_number] => 10/106580 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3442 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593316.pdf [firstpage_image] =>[orig_patent_app_number] => 10106580 [rel_patent_id] =>[rel_patent_doc_number] =>)